Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New appointment at Calistoga

This article was originally published in Scrip

Executive Summary

Calistoga Pharmaceuticals (US) has named Langdon Miller executive vice-president of R&D. Dr Miller has more than 20 years' drug development experience, with previous roles including chief medical officer at PCT Therapeutics and vice-president of global oncology clinical research at Pharmacia.

You may also be interested in...



Adeona makes appointment

Adeona has appointed Julie Caudill vice-president of finance and corporate controller. Ms Caudill has more than 15 years' biotechnology-related accounting and Securities and Exchange Commission compliance experience, having previously served as corporate controller and corporate secretary at Aastrom and as accounting manager at KMS Industries.

Pharminox makes board appointment

Pharminox has appointed Dr Marc Hummersone to its board of directors as research director. Dr Hummersone joined the company from KuDOS Pharmaceuticals in April 2008 as head of chemistry. The UK-based cancer drug discovery and development company has also announced that Professor Malcolm Stevens is standing down from the board and as chief scientific officer, and will take up the honorary position of CSO Emeritus.

New CEO at CMP Therapeutics

CMP Therapeutics (UK) has appointed Dr Neill Moray Mackenzie chief executive officer. He succeeds Dr Bruce Savage, who is leaving the company. Dr Mackenzie has management experience in the pharmaceutical and biotech industries, having most recently served as senior vice-president for business development and corporate strategy at Medigene and as CEO of Roji.

UsernamePublicRestriction

Register

SC009777

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel